中文
Home
Protocols
Biochemistry
Biophysics
Cancer Biology
Cell Biology
Developmental Biology
Immunology
Microbiology
Molecular Biology
Neuroscience
Plant Science
Stem Cell
Systems Biology
Archive
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
About Us
A peer-reviewed protocol journal. No publication fee; no access fee.
Search
Overview
Published
Edited
Reviewed
Following
Feedback
Q&A
Kyun-Hwan Kim
Department of Pharmacology and Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, KU Open Innovation Center and Research Institute of Medical Sciences, Konkuk University, South Korea
2 protocols
Sung Ahn
Department of Pharmacology and Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, KU Open Innovation Center and Research Institute of Medical Sciences, Konkuk University, South Korea
2 protocols
View all coauthors >
Yong Kwang Park
Department of Pharmacology and Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, KU Open Innovation Center and Research Institute of Medical Sciences, Konkuk University, South Korea
Research focus
Microbiology
Contributions
2
Author merit
Reviewer merit
Editor merit
2 Protocols published
Introduction and Sequencing of Patient-isolated HBV RT Sequences into the HBV 1.2-mer Replicon
Authors:
Sung Hyun Ahn
,
Yong Kwang Park
and
Kyun-Hwan Kim
,
date:
04/20/2015,
view:
8201,
Q&A:
0
Antiviral agents for the suppression of hepatitis B virus (HBV) have been used for treating chronic hepatitis B. However, the emergence of drug-resistant HBV is still a major problem for antiviral treatment. To identify and characterize the ...
More >
In vitro
Drug Susceptibility Assay for HBV Using Southern Blotting
Authors:
Sung Hyun Ahn
,
Yong Kwang Park
and
Kyun-Hwan Kim
,
date:
04/20/2015,
view:
9744,
Q&A:
0
Antiviral agents for the suppression of hepatitis B virus (HBV) have been used for treating chronic hepatitis B. However, the emergence of drug-resistant HBV is still a major problem for antiviral treatment. To identify and characterize the ...
More >
following
More protocols >
0 Protocol feedback
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.